Showing results (261-270 of 283) with videos related to
Sort By:
Pageof 29
Public Health Genomics|April 16, 2009
A health services research agenda for cellular, molecular and genomic technologies in cancer careLouise Wideroff, Kathryn A Phillips, Gurvaneet Randhawa, et al.Urologic Oncology|March 26, 2013
Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordanceDavid E Victorson, Penny S Brucker, Rita K Bode, et al.Journal of Oncology Practice|December 4, 2014
Economics of Malignant Gliomas: A Critical ReviewJeffrey J Raizer, Karen A Fitzner, Daniel I Jacobs, et al.Journal of General Internal Medicine|June 14, 2012
Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR)Charles L Bennett, Karen M Starko, Henrik S Thomsen, et al.The New England Journal of Medicine|October 2, 2004
Pure red-cell aplasia and epoetin therapyCharles L Bennett, Stefano Luminari, Allen R Nissenson, et al.Journal of the American College of Cardiology|January 3, 2006
Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) projectJonathan R Nebeker, Renu Virmani, Charles L Bennett, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2014
Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guidelineEthan Basch, D Andrew Loblaw, Thomas K Oliver, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2021
Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline UpdateKatherine S Virgo, R Bryan Rumble, Ronald de Wit, et al.The Lancet. Oncology|December 3, 2014
Regulatory and clinical considerations for biosimilar oncology drugsCharles L Bennett, Brian Chen, Terhi Hermanson, et al.Kidney International. Supplement|January 31, 2009
Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008)Anaadriana Zakarija, Hau C Kwaan, Joel L Moake, et al.Pageof 29